| 发明名称 |
Method of optimizing the treatment of proliferative diseases mediated by the tyrosine kinase receptor KIT with imatinib |
| 摘要 |
H:/rbr/Intenvoven/NRPottb/DCC/RBR/020933 I. DOC-26/03/2013 Abstract The invention relates to a method of treating proliferative diseases mediated by the tyrosine kinase receptor KIT, in particular GIST, in a human patient population. |
| 申请公布号 |
AU2013201993(B2) |
申请公布日期 |
2014.10.09 |
| 申请号 |
AU20130201993 |
申请日期 |
2013.03.26 |
| 申请人 |
NOVARTIS AG |
发明人 |
WANG, YANFENG;WEHRLE, ELISABETH |
| 分类号 |
A61K31/506;A61P35/00 |
主分类号 |
A61K31/506 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
